Clinical Perspectives

Methylthioadenosine Phosphorylase (MTAP) Pathway for Genitourinary Cancers

There are several options currently available for the initial treatment of prostate, bladder, and kidney cancer.  However, there’re limited resources...

Radiation Oncologist Relates to Cancer Patients 'More Than They Know'

Dr. Roberto Diaz was the section head for Breast Oncology in the Department of Radiation Oncology when he was diagnosed with kidney cancer.

FDA Approves Targeted Radioligand Therapy for Treatment of Advanced Prostate Cancer

The FDA approval of Pluvicto™ is welcome news and an important medical advancement for patients with progressing metastatic castration-resistant...

Engaging the Community Against Cancer

To close the disparity gap in health care, it is critical that medical centers and community organizations work collaboratively to ensure that...

Working to Overcome Health Disparities

At Moffitt Cancer Center we are dedicated to prioritizing the needs of the community we serve, and emphasizing the importance of screening, early...

Sarcoma is Not a Single Disease, There are Actually More Than 70 Subtypes

Sarcoma is a relatively rare type of cancer, accounting for only about 1% of all malignancies in the U.S. Learn more about the types of sarcoma here.

Second-Line Therapy for Large B-Cell Lymphoma

In a recent article published in The New England Journal of Medicine hematologist Dr. Fred Locke at Moffitt Cancer Center details this international,...

Promises of Cell Therapy Bring Opportunities for Collaboration and Clinical Excellence

Finding ways to act on discrete targets on or within cancerous cells without affecting healthy cells is a key focus of several Moffitt research...

The Latest Research in Head and Neck-Endocrine Cancer Treatment

The Head and Neck-Endocrine Oncology Program joined in an engaging conversation exploring the latest research in cancer treatment. Learn more here.

Advanced Renal Cell Carcinoma Patients Sought for Autologous Dendritic Cell Immunotherapy Clinical Trial

Moffitt is recruiting adult patients with advanced renal cell carcinoma (RCC) scheduled or soon-to-be-scheduled to receive a nephrectomy or a biopsy...

Moffitt Researchers Lead Study Identified ctDNA for the Treatment of High-Risk Urothelial Carcinoma

Our Genitourinary Oncology department at Moffitt Cancer Center conducted a study using circulating tumor DNA to refine staging for high-risk upper...

Q&A: Dr. Agosto Shares Her Role as an Endocrine Oncologist

Salimar Agosto Salgado, MD, an associate member of the Department of Head and Neck-Endocrine Oncology, shares her experience as a dually trained...

Dr. Vogelbaum Leads the Development of the National Guidelines for Metastatic Brain Tumor Treatment

A multidisciplinary panel of experts, including Dr. Michael Vogelbaum, collaborated in a highly-structured guideline development process to address...

U.S. House Passes HPV Cancer Legislation

The United States House of Representatives recently passed the PREVENT HPV Cancers Act by voice vote. Anna Giuliano, PhD, director of Moffitt's...

Cancer Immunotherapy Breakthrough: Dendritic Cell Vaccines

The latest addition to oncotherapy is the use of dendritic cell (DC) vaccine therapy. Dendritic cell vaccine is a cross between a vaccine and a cell...